Get ready for February 18th.
That’s when members of the state’s two physician licensing boards begin working on the practice standards Florida-licensed physicians must follow when ordering smokable medical marijuana for their qualified patients. The Board of Medicine and the Board of Osteopathic Medicine are required to have the rules adopted by July 1.
As members of the boards, meeting collectively as the Joint Committee on Medical Marijuana (not kidding), begin working on rules laying out when smoking is acceptable, they will be reviewing the findings of a new sate report that shows smoking medical marijuana is popular among patients who qualify.
A new Department of Health report shows that 584,227 certifications for smoking were issued to 400,892 patients between Oct. 1, 2019 and Sept. 30, 2020. The report, published annually by the state, is compiled of data collected by the Florida Department of Health’s Office of Medical Marijuana Use.
The report also shows that the average amount of smokable marijuana physicians certified during the 12-month period was 2.46 ounces, slightly higher than the 2.4 ounces that physicians certified between March 18, 2019 — when smoking became a legal route of administration — and Sept. 30, 2019.
Post-traumatic stress disorder continues to be the most common condition of patients who have certifications for smokable medical marijuana, accounting for 37.5 percent of the certifications.
Physicians aren’t the only ones getting into the medical marijuana weeds on Wednesday, however.
The House Professions & Public Health Subcommittee will hear from Bertha Madras, a Harvard Medical School professor of psychobiology who will discuss the negative effects of high-potency marijuana.
The Council of Medical Physicists proposes amending Rule 64B23-7.001 to update the form to apply for licensure as a medical physicist in training. More here.
The Board of Osteopathic Medicine proposes amending Rule 64B15-13.0025 to clarify the requirement for continuing education courses on prescribing controlled substances. More here.
The Board of Osteopathic Medicine proposes amending Rule 64B15-14.0075 to revise the adverse-incident reporting form. More here.
The Board of Medicine proposes amending Rule 64B8-9.001 to revise the adverse-incident reporting form. More here.